Monitor for additional insider selling in the coming weeks; single-executive sales of this size are typically routine, but could signal caution if followed by broader divestments or negative news.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 4 $12.50entry
- T+1 · 9mo ago −7.04%α −6.47% · $11.62
- T+5 · 8mo ago +8.00%α +9.33% · $13.50
- T+20 · 8mo ago +7.84%α +12.26% · $13.48
- T+60 · 6mo ago −45.44%α −55.53% · $6.82
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Entrada Therapeutics President & COO Nathan J. Dowden sold a total of 15,010 shares in the past week for approximately $195,771 in open-market transactions. The sales represent a modest insider divestment by a single C-suite executive.
Key Financial Metrics
Key Facts
- President & COO Nathan J. Dowden sold 15,010 shares over two days (11,894 shares on 2026-03-10 at $13.0476; 3,116 shares on 2026-03-09 at $13.024).
- Total proceeds from the sales were $195,770.93.
- All transactions were open-market sales (Form 4 codes 'S').
- No other insiders participated in this cluster.
Financial Impact
$195,771 in total sales, representing ~0.039% of company's $505M market cap
Risk Factors
- Potential perception of insider lack of confidence if no offsetting positive developments emerge.
- Concentration of selling in a short window may attract short-term trader attention despite low overall magnitude.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-TRDA-1773261430415 |
Track record
21 reports on TRDA
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +58.22% at T+20 after the May 4, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 4/10 No price data
- Nov 5, 202611d ago Press Release Neutral 4/10 Entry $4.55 Now $5.00 +9.89% settles Feb 3
- Oct 14, 20264w ago 8-K Bullish 6/10 Entry $4.55 Now $5.00 +9.89% settles Jan 11
- Sep 9, 20269w ago Insider Cluster Bearish 6/10 Entry $6.42 Now $5.00 +22.12% settles Dec 4
- Sep 3, 202610w ago Insider Cluster Neutral 3/10 Entry $7.13 Now $5.00 −29.87% settles Dec 1
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 3/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $7.27 Now $5.00 −31.22% settles Nov 20
- Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $7.04 to $5.06 Now $5.00 −28.98% ▼ −28.13% −27.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers